Search our Database of Scientific Publications and Authors

I’m looking for a

    1920 results match your criteria Canadian Journal of Urology[Journal]

    1 OF 39

    How I Do It: Hydrogel spacer placement in men scheduled to undergo prostate radiotherapy.
    Can J Urol 2018 Apr;25(2):9288-9293
    The Urology Center of Colorado, Denver, Colorado, USA.
    Hydrogel spacer placement between the prostate and rectum in men scheduled to undergo prostate radiotherapy is an emerging technique well suited for urologists. The hydrogel spacer reduces rectal injury during radiotherapy by displacing the rectum away from the high dose region. Following radiotherapy the hydrogel spacer then liquifies, is absorbed, and then clears via renal filtration in approximately 6 months. Read More

    Secondary mucinous carcinoma of the prostate after low dose rate brachytherapy.
    Can J Urol 2018 Apr;25(2):9284-9287
    Department of Radiation Oncology, University of British Columbia, Vancouver, British Columbia, Canada.
    Radiation induced malignancy (RIM) after treatment for prostate cancer is well documented after external beam irradiation, but less so in the setting of brachytherapy. We report a case of mucinous adenocarcinoma of the prostate, consistent with a RIM, which developed 12 years after low dose rate brachytherapy for low risk prostate adenocarcinoma. Diagnostic and therapeutic considerations of RIM are discussed. Read More

    The disappearing PI-RADS 5 prostate lesion.
    Can J Urol 2018 Apr;25(2):9281-9283
    Department of Urology, George Washington University Hospital, Washington, DC, USA.
    Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) identifies prostate cancer on the basis of multiparametric MRI (mpMRI). As an assessment tool, it correctly predicts clinically significant cancer in the vast majority of cases. In this light, we report a rare patient, for whom a PI-RADS 5 lesion vanished over the course of 13 months. Read More

    Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
    Can J Urol 2018 Apr;25(2):9273-9280
    Department of Urology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
    Introduction: To evaluate the efficacy and safety of intraprostatic injections of onabotulinumtoxinA (onaBoNT-A) to treat refractory chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

    Materials And Methods: Prospective two-group controlled study. Treatment group included adult men with refractory category-III nonbacterial CP/CPPS who underwent transurethral intraprostatic injections of onaBoNT-A (200 U). Read More

    The transobturator suburethral sling: a safe and effective option for all degrees of post prostatectomy urinary incontinence.
    Can J Urol 2018 Apr;25(2):9268-9272
    Department of Urological Surgery, St James's Hospital, Dublin, Ireland.
    Introduction: Male stress urinary incontinence (SUI) after radical prostatectomy (RP) is common. The surgical standard of care traditionally has been placement of an artificial urinary sphincter (AUS) but since its introduction the transobturator male sling has been shown to have particular unique advantages. Our aim was to assess outcomes of a consecutive series of suburethral sling insertions in men presenting with all degrees of post RP SUI. Read More

    Open radical prostatectomy after transurethral resection: perioperative, functional, oncologic outcomes.
    Can J Urol 2018 Apr;25(2):9262-9267
    Department of Urology, Athens General Hospital 'G. Gennimatas', Athens, Greece.
    Introduction: To demonstrate any differences in the perioperative, functional and oncologic outcomes after radical retropubic prostatectomy (RRP) among those patients having previously performed transurethral resection of prostate (TURP) and those not.

    Materials And Methods: A total of 35 patients were diagnosed with prostate cancer (T1a and T1b) after TURP, underwent RRP and completed a 1 year follow up (group A). They were matched with a cohort of another 35 men (group B) in terms of age, body mass index (BMI), prostatic specific antigen (PSA), Gleason score, prostate volume (before surgery), pathological stage and neurovascular bundle-sparing technique. Read More

    The comparative effectiveness of quadratus lumborum blocks and paravertebral blocks in radical cystectomy patients.
    Can J Urol 2018 Apr;25(2):9255-9261.
    School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
    Introduction: Multimodal analgesia is an effective way to control pain and limit opioid use after surgery. The quadratus lumborum block and paravertebral block are two regional anesthesia techniques that leverage multimodal analgesia to improve postoperative pain control. We sought to compare the efficacy of these blocks for pain management following radical cystectomy. Read More

    Improving the utility of clinical phenotyping in interstitial cystitis/painful bladder syndrome: from UPOINT to INPUT.
    Can J Urol 2018 Apr;25(2):9250-9254
    Glickman Urological and Kidney Institute, Cleveland, Ohio, USA.
    Introduction: The phenotyping system UPOINT has proven effective in classifying patients with Urologic Pelvic Pain Syndromes in a clinically meaningful way and to guide therapy. While highly successful in men with chronic pelvic pain syndrome (CPPS), UPOINT is more limited in patients with interstitial cystitis/painful bladder syndrome (IC/PBS) since by definition all patients have the urinary and organ specific phenotype. Furthermore, AUA guidelines recommend a sequential tiered approach to therapy rather than the multimodal UPOINT scheme. Read More

    Supine percutaneous nephrolitotripsy in septuagenarian and octogenarian patients: outcomes of a case-control study.
    Can J Urol 2018 Apr;25(2):9245-9249
    Division of Urology, Department of Surgery, University of Sao Paulo Medical School, Sao Paulo, Brazil.
    Introduction: Currently, there is a paucity of data evaluating the outcomes of supine percutaneous nephrolithotomy (PCNL) in septuagenarian and octogenarian patients. In this study we aim to compare the outcomes of supine PCNL in elderly patients with those of younger population.

    Material And Methods: A matched case-control study was performed from January 2009 through December 2015 using our prospectively collected kidney stone database. Read More

    Stone culture in patients undergoing percutaneous nephrolithotomy: a practical point of view.
    Can J Urol 2018 Apr;25(2):9238-9244
    Unit of Endourology, Rabin Medical Center, Petah Tikva, Israel.
    Introduction: To determine the clinical yield of stone culture in patients undergoing percutaneous nephrolithotomy (PCNL), and to identify patients who may benefit from this test.

    Materials And Methods: We queried our database for all patients who underwent PCNL from 2005 to 2017, from whom urine culture (UC) and stone culture (SC) were obtained. Study endpoint was systemic inflammatory response syndrome (SIRS) within 48 hours of PCNL. Read More

    Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
    Can J Urol 2018 Apr;25(2):9228-9237
    Department of Urology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
    Introduction: Oral therapy with alpha-blockers or 5-alpha reductase inhibitors remains the most common treatment in men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hypertrophy (BPH). For patients who progress or fail medical therapy, the standard of care surgical treatment continues to be transurethral resection of the prostate (TURP), which has long-studied and durable outcomes. Emerging, minimally invasive options for LUTS secondary to the BPH, however, have been developed over the last decade with promising results and minimal side effects typically associated with TURP, such as retrograde ejaculation and erectile dysfunction. Read More

    Bilateral hydronephrosis and acute kidney injury secondary to pelvis lipomatosis.
    Can J Urol 2018 Feb;25(1):9217-9219
    Division of Urology, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
    A 57-year-old African American male presented with vague abdominal pain and bilateral flank pain. The patient was found to have bilateral hydronephrosis and significant renal function impairment secondary to pelvic lipomatosis. Pelvic lipomatosis represents a clinically-diagnosed unique cause of ureteral obstruction and subsequent renal impairment. Read More

    T4 urothelial carcinoma in undiagnosed closed bladder exstrophy in a post-menopausal female.
    Can J Urol 2018 Feb;25(1):9214-9216
    Division of Urology, Department of Surgery, Cook County Health and Hospitals System, Chicago, Illinois, USA.
    It is rare to see an adult presenting with exstrophy of the bladder. Malignant conversion in exstrophy occurs in 4%, with adenocarcinoma as the most common histopathology. We report the first case of metastatic high grade urothelial carcinoma with squamous and sarcomatoid differentiation arising from undiagnosed, closed bladder exstrophy in a female at advanced age with associated bilateral deep vein thrombosis and clot retention. Read More

    Retroperitoneal Leydig cell tumor recurrence presenting 14 years after orchiectomy.
    Can J Urol 2018 Feb;25(1):9210-9213
    Department of Urology, Oregon Health & Science University, Portland, Oregon, USA.
    Malignant Leydig cell tumor is a rare entity that has been previously described as rapidly progressive and uniformly fatal. We present the case of a malignant Leydig cell tumor that presented 14 years after orchiectomy with an isolated retroperitoneal metastasis. Our patient underwent a retroperitoneal lymph node dissection and has been free of recurrence or progression at 12 months of follow up. Read More

    Fluoroless-ureteroscopy for definitive management of distal ureteral calculi: randomized controlled trial.
    Can J Urol 2018 Feb;25(1):9205-9209
    Department of Urology, Benha Faculty of Medicine, Benha University, Benha, Egypt.
    Introduction: To assess the conversion rate during fluoroless-ureteroscopy (URS) and evaluate the feasibility, safety, and efficacy of fluoroless-URS as a definitive management of distal ureteral calculi.

    Material And Methods: Between May 2013 and August 2015, patients with radio-opaque distal ureteral calculi of ≤ 1 cm in size were randomized to undergo fluoroless-URS or standard URS. Patients with previous ureteral surgery, ureteral kinking, ureteral stricture, single kidney, additional proximal ureteral or renal calculi, uncontrolled coagulopathy, and/or congenital anomalies of the urinary tract were excluded. Read More

    Urine kidney injury markers do not increase following gastric bypass: a multi-center cross-sectional study.
    Can J Urol 2018 Feb;25(1):9199-9204
    Glickman Urologic and Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
    Introduction: To determine if markers of kidney injury correlate with urinary oxalate excretion. If so, such biomarkers might be early predictors of oxalate nephropathy. Gastric bypass surgery for obesity is known to be associated with postoperative hyperoxaluria, which can lead to urolithiasis and kidney damage. Read More

    African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Can J Urol 2018 Feb;25(1):9193-9198
    Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
    Introduction: Prior studies suggest that among men with low grade prostate cancer, African Americans (AA) produce less prostate-specific antigen (PSA) than Caucasians. We investigated racial differences in PSA, PSA density (PSAD), and tumor volume among men with prostate cancer, regardless of tumor grade. These racial differences, if present, would suggest that AA men may benefit from different screening, surveillance, and treatment regiments compared to Caucasians. Read More

    Implications of postoperative pulmonary aspiration following major urologic surgery.
    Can J Urol 2018 Feb;25(1):9186-9192
    Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA.
    Introduction: The purpose of this article is to assess the incidence of pulmonary aspiration following major urologic surgery, predictors of an aspiration event, and subsequent clinical outcomes.

    Materials And Methods: The Healthcare Cost and Utilization Project State Inpatient Database for California between 2007-2011 was used to identify cystectomy, prostatectomy, partial and radical nephrectomy patients. Aspiration events were identified within 30 days of surgery. Read More

    Sociodemographic and survival disparities for histologic variants of bladder cancer.
    Can J Urol 2018 Feb;25(1):9179-9185
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA.
    Introduction: To investigate the impact of perioperative factors on overall survival among patients with histologic variants of bladder cancer treated with radical cystectomy.

    Materials And Methods: The National Cancer Data Base was utilized to identify patients diagnosed with muscle-invasive bladder cancer (cT2-4, N0, M0) from 2004-2013. Variant histology bladder cancers (non-mucinous adenocarcinoma, mucinous/signet ring adenocarcinoma, micropapillary urothelial carcinoma, small cell carcinoma, and squamous cell carcinoma) were compared to urothelial carcinoma with respect to overall survival. Read More

    Analysis of evidence within the AUA's clinical practice guidelines.
    Can J Urol 2018 Feb;25(1):9168-9178
    Department of Urology, Columbia University Irving Medical Center, New York, New York, USA.
    Introduction: Surgical subspecialty societies release clinical practice guidelines (CPGs) to provide topic-specific recommendations to healthcare providers. We hypothesize that there may be significant differences in statement strength and evidence quality both within the American Urological Association (AUA) guidelines and compared to those published by the American Academy of Orthopedic Surgeons (AAOS) and American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS).

    Materials And Methods: CPGs issued through 2017 were extracted from the AUAnet. Read More

    Analysis of bladder cancer subtypes in neurogenic bladder tumors.
    Can J Urol 2018 Feb;25(1):9161-9167
    Sorbonne Université, GRC n°5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière, F-75013, Paris, France.
    Introduction: To establish if the validated tumor biomarkers of luminal and basal bladder cancers in non neuro-urological patients are applicable to a neuro-urological population.

    Materials And Methods: We retrieved bladder cancer samples from neuro-urological patients (n = 20) and non-neurological controls (n = 40). The expression of GATA3 and CK5/6 was analyzed using immunohistochemistry of microarray tissue sections. Read More

    Identifying and managing the risks of medical ionizing radiation in endourology.
    Can J Urol 2018 Feb;25(1):9154-9160
    Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
    Introduction: The risks of exposure to medical ionizing radiation is of increasing concern both among medical professionals and the general public. Patients with nephrolithiasis are exposed to high levels of ionizing radiation through both diagnostic and therapeutic modalities. Endourologists who perform a high-volume of fluoroscopy guided procedures are also exposed to significant quantities of ionizing radiation. Read More

    Recurrent renal cell carcinoma presenting as a solitary left ventricular mass.
    Can J Urol 2017 Dec;24(6):9145-9147
    Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
    A 73-year-old male with a remote history of renal cell carcinoma presented with an asymptomatic left ventricular mass. Biopsy of the mass revealed a late recurrence of his renal cell carcinoma. Given the size and location of the mass, resection was not possible. Read More

    Blueprint unknown: a case for multidisciplinary management of advanced penile mycosis fungoides.
    Can J Urol 2017 Dec;24(6):9139-9144
    Department of Surgery, Austin Health, The University of Melbourne, Victoria, Australia.
    A 64-year-old man presented with a 2 week history of progressive phimosis and painful ulcer on his penile meatus. He underwent penile preserving excision, and subsequent pathological examination confirmed T-cell non-Hodgkin lymphoma with immunohistochemical features of large cell transformation of mycosis fungoides. The penis was further treated with local external beam radiotherapy consisting of 27 Gy in 15 fractions and systemic mini-CHOP chemotherapy. Read More

    Subcutaneous emphysema following cystoscopic clot evacuation.
    Can J Urol 2017 Dec;24(6):9137-9138
    Department of Urology, Alpert Medical School of Brown University, Providence, Rhode Island, USA.
    Gross hematuria is a common urologic problem which often requires surgical intervention. While generally a safe procedure, clot evacuation can have serious complications. Here we describe the case of an 85-year-old male who developed extensive subcutaneous emphysema following a small extraperitoneal bladder perforation during a clot evacuation. Read More

    Benign fibrous pseudotumor resulting in orchiectomy despite intraoperative frozen section.
    Can J Urol 2017 Dec;24(6):9132-9136
    Department of Urology, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, USA.
    Fibrous pseudotumors are rare benign lesions that originate within the paratesticular tissues. Local excision is the preferred method of treatment of these tumors over radical orchiectomy, however a definitive diagnosis must be made beforehand given the similarity of these tumors to malignant entities. We present a case of fibrous pseudotumor of the tunica vaginalis and cauda epididymis. Read More

    Ultrasound self-referral does not increase utilization in pediatric urology.
    Can J Urol 2017 Dec;24(6):9127-9131
    Division of Pediatric Urology, Cohen Children's Medical Center of NY, Hofstra Northwell School of Medicine, Long Island, New York, USA.
    Introduction: Costs of radiologic imaging are rising. The goal of this study is to examine the utilization practices of pediatric urologists who have access to in-office ultrasound imaging when managing children with primary hydronephrosis.

    Materials And Methods: A retrospective cross sectional study was performed of children ≤ 5 years old with an isolated diagnosis of hydronephrosis. Read More

    AdVance sling use decreasing relative to artificial urinary sphincters.
    Can J Urol 2017 Dec;24(6):9121-9125
    Department of Urology, Naval Medical Center San Diego, San Diego, California, USA.
    Introduction: To evaluate the percent of AdVance male sling usage relative to artificial urinary sphincters (AUS) over a 9 year period since its introduction in order to assess trends across the United States.

    Materials And Methods: As a surrogate for procedures performed, we reviewed device utilization trends of the AdVance sling and AUS broken down by American Urological Association (AUA) section. ANOVA testing between years was used to determine purchasing trends with p values of < 0. Read More

    Assessment of bilateral supine and prone tubeless percutaneous nephrolithotomy.
    Can J Urol 2017 Dec;24(6):9114-9120
    Endourology Unit, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel.
    Introduction: To assess the outcome of same-session bilateral tubeless percutaneous nephrolithotomy (BPCNL) in supine and prone positions and to compare them to unilateral tubeless PCNL (UPCNL).

    Materials And Methods: Consecutive PCNL patients treated at two institutions between 2006-2016 were analyzed. Tubeless BPCNL was performed when indicated. Read More

    Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron.
    Can J Urol 2017 Dec;24(6):9107-9113
    Urology Department, School of Medicine, Ioannina University, Ioannina, Greece.
    Introduction: Multiple sclerosis (MS) is the commonest progressive neurological disease affecting young people. With advancing disease, management of neurogenic detrusor overactivity (NDO) based on antimuscarinics may prove inadequate and if based on botulinum toxin, may necessitate clean intermittent self-catheterization. The aim of the study was to evaluate the effectiveness of combined mirabegron and desmopressin administration in the treatment of NDO in patients with MS. Read More

    Comparison of two indices to annotate complications after radical nephroureterectomy.
    Can J Urol 2017 Dec;24(6):9103-9106
    Department of Urology, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
    Introduction: The Clavien-Dindo (CD) and Comprehensive Complication Index (CCI) are two grading systems that annotate adverse events following surgical procedures. We compare these two classification systems in a cohort of patients undergoing radical nephroureterectomy (RNU).

    Materials And Methods: The charts of 110 consecutive RNU patients were reviewed for complications occurring within 30 days of surgery. Read More

    Laparoendoscopic single-site surgery for treatment of urachal remnants.
    Can J Urol 2017 Dec;24(6):9098-9102
    Department of Urology and Andrology, Kansai Medical University, Osaka, Japan.
    Introduction: To evaluate safety and excellent cosmetic outcome with laparoendoscopic single-site surgery (LESS). In this study, we compared the usefulness and efficacy of LESS versus conventional laparoscopic surgery for the treatment of urachal remnants.

    Materials And Methods: We retrospectively reviewed the medical records of 20 consecutive patients who underwent either conventional laparoscopic surgery or LESS from January 2007 to February 2015 at Kansai Medical University Hospital. Read More

    Two-stage classifiers that minimize PCA3 and the PSA proteolytic activity testing in the prediction of prostate cancer recurrence after radical prostatectomy.
    Can J Urol 2017 Dec;24(6):9089-9097
    Department of Biostatistics, City of Hope, Duarte, California, USA.
    Introduction: Early biochemical recurrence after prostate cancer surgery is associated with higher risk of aggressive disease and cancer specific death. Many new tests are being developed that will predict the presence of indicators of aggressive disease like early biochemical recurrence. Since recurrence occurs in less than 10% of patients treated for prostate cancer, validation of such tests will require expensive testing on large patient groups. Read More

    Biologic and epidemiologic evidence assessing if statins prevent prostate cancer.
    Can J Urol 2017 Dec;24(6):9081-9088
    Department of Hematology and Medical Oncology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
    Introduction: During their lives, 1 in 8 men will be diagnosed with prostate cancer. Several drugs have been shown to decrease prostate cancer risk, but have not been widely used in prostate cancer prevention because of concerns about side-effects and cost-effectiveness. Statins are indicated for prevention of cardiovascular disease, have an excellent benefit to risk profile, and some studies suggest that statins may reduce the risk of prostate cancer. Read More

    The practical update for family physicians in the diagnosis and management of overactive bladder and lower urinary tract symptoms.
    Can J Urol 2017 Oct;24(5S1):1-11
    Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
    Objective: To provide family physicians with an up-to-date, practical overview of the diagnosis and management of overactive bladder (OAB) alone or with bladder outlet obstruction.

    Main Message: OAB is urinary urgency with or without incontinence, often accompanied by frequency and nocturia, in the absence of urinary tract infection and can affect both men and women. Men often have co-existing OAB associated with bladder outlet obstruction, and benign prostatic hyperplasia. Read More

    Bowel preparation prior to reconstructive urologic surgery in pediatric myelomeningocele patients.
    Can J Urol 2017 Oct;24(5):9038-9042
    Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
    Introduction: Mechanical bowel preparation (MBP) has historically been the standard of care for patients undergoing reconstructive urologic surgery, including urinary diversion. To date, several studies have examined the role of mechanical bowel preparation in postoperative outcomes in pediatric patients undergoing augmentation cystoplasty. However, these patient populations have been heterogeneous in nature, with no studies dedicated to examining the role of MBP prior to reconstructive urologic surgery in pediatric patients with myelomenginoceles. Read More

    Urothelial melanosis of the bladder.
    Can J Urol 2017 Oct;24(5):9035-9037
    Division of Urology, University of Connecticut Health Center, Farmington, Connecticut, USA.
    Urothelial melanosis is a rare finding characterized by abnormal pigmentation noted on cystoscopic evaluation and histologically defined by melanin deposition in the urothelium. Although generally considered benign, few cases of urothelial melanosis have been reported in the literature and the risk of recurrence or progression remains largely unknown. Four cases associated with urothelial cell carcinoma have been previously described. Read More

    Modification of tubeless percutaneous nephrolithotomy with a ureteropelvic junction stent.
    Can J Urol 2017 Oct;24(5):9030-9034
    Department of Urology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
    Introduction: To introduce the ureteropelvic junction stent as a safe and effective modification to tubeless percutaneous nephrolithotomy for select patients to maintain antegrade access to the collecting system.

    Materials And Methods: From April 2014 to December 2015, 31 patients underwent modified tubeless percutaneous nephrolithotomy with ureteropelvic junction (UPJ) stent left in situ and an extraction string coming out the nephrostomy tract. Primary study endpoints included complications, emergency department visits, or re-admissions. Read More

    Spontaneous passage of ureteral stones in patients with indwelling ureteral stents.
    Can J Urol 2017 Oct;24(5):9024-9029
    Department of Urology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
    Introduction: To determine rates of spontaneous ureteral stone passage in patients with indwelling ureteral stents, and to identify factors associated with the spontaneous passage of stones while a ureteral stent is in place.

    Materials And Methods: From our institutional database, we identified patients who underwent ureteroscopic procedures for stone disease between January 1, 2013 and March 1, 2015. We compared the rates of spontaneous stone passage between patients who had previously undergone ureteral stent placement and those who had not. Read More

    Sepsis after elective ureteroscopy.
    Can J Urol 2017 Oct;24(5):9017-9023
    Department of Urology, New York Medical College, Valhalla, New York, USA.
    Introduction: We sought to determine our rate of postoperative sepsis after ureteroscopy as well as identifying associative factors, common antibiotic practices along with culture data.

    Materials And Methods: Records of all patients who underwent elective ureteroscopy from 2010 to 2015 at an urban tertiary care facility were retrospectively reviewed. Factors thought to be associated with infection were collected, along with comorbidities depicted as Charlson Age-Adjusted Comorbidity Index (CAACI) and American Society of Anesthesia (ASA) score. Read More

    1 OF 39